The sufficient invasion and migration of human extravillous trophoblast (EVTs) cells are crucial for placentation. Inadequate invasion of trophoblasts may correlate with the development of preeclampsia. Many studies have suggested that activated Cdc42-associated kinase (ACK1) is associated with tumor metastasis and invasion. This study investigated the ACK1 expression and its function in trophoblasts during placental development. ACK1 expression in human placentas was determined through immunofluorescence. We investigated the migration/invasion of the immortalized human first-trimester EVT cell line HTR8/SVneo. Hypoxia-reoxygenation (H/R) conditions were applied to mimic preeclampsia model . Lentiviral vector-based short-hairpin RNA directed against the sequence of ACK1 (ACK1 shRNA) was used to knock down ACK1 expression in HTR8/SVneo cells. Cell apoptosis and proliferation were determined through flow cytometry and cell counting Kit-8 (CCK-8) assays, respectively. The expression of matrix metalloproteinase (MMP) 2/9 and tissue inhibitors of metalloproteinase (TIMP) 1/2 was measured by western blotting. ACK1 localized within trophoblasts of human placental villi, decidual cells in the maternal decidua. ACK1 levels in preeclampsia (PE) placentas were significantly lower than those in controls. ACK1 shRNA significantly inhibited HTR8/SVneo cells migration and invasion but did not affect their apoptosis and proliferation. ACK1 knockdown decreased MMP2/9 and increased TIMP1/2 expression, as well as downregulated the phosphorylation of AKt (p-Akt). In addition, ACK1 and MMP2/9 were downregulated following treatment with LY294002, whereas ACK1 shRNA had no effect on phosphorylation of PI3K(p-PI3K). After exposed in H/R condition, ACK1 expression, MMP2/9 protein, and p-Akt were also significantly decreased. ACK1 expression is lowered in preeclamptic placentas and promotes trophoblast cell invasion, migration. H/R conditions decrease ACK1 expression and appear to decouple the positive relationship between ACK1 expression and Akt activation.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767058.2018.1515196DOI Listing

Publication Analysis

Top Keywords

ack1 expression
28
ack1
16
ack1 shrna
12
expression
10
activated cdc42-associated
8
cdc42-associated kinase
8
human extravillous
8
extravillous trophoblast
8
migration invasion
8
matrix metalloproteinase
8

Similar Publications

Article Synopsis
  • The study focuses on an oriental herbal plant, PO, known for treating alopecia (hair loss) in Eastern Asia but lacking scientific evidence on its effects on hair growth.
  • Researchers found that the leaf extract (POLE) significantly promotes the proliferation of human dermal papilla cells (hDPCs) and enhances cell viability, particularly when rich in quercitrin.
  • POLE treatment led to decreased expression of cellular senescence markers and activated key growth factor receptors and signaling pathways, ultimately increasing growth factors like KGF, which suggests a potential for supporting terminal hair growth.
View Article and Find Full Text PDF

Mutations that decrease or increase the activity of the tyrosine phosphatase, SHP2 (encoded by PTPN11), promotes developmental disorders and several malignancies by varying phosphatase activity. We uncovered that SHP2 is a distinct class of an epigenetic enzyme; upon phosphorylation by the kinase ACK1/TNK2, pSHP2 was escorted by androgen receptor (AR) to chromatin, erasing hitherto unidentified pY54-H3 (phosphorylation of histones H3 at Tyr54) epigenetic marks to trigger a transcriptional program of AR. Noonan Syndrome with Multiple Lentigines (NSML) patients, SHP2 knock-in mice, and ACK1 knockout mice presented dramatic increase in pY54-H3, leading to loss of AR transcriptome.

View Article and Find Full Text PDF

Phosphorylation of Ack1 by the Receptor Tyrosine Kinase Mer.

Kinases Phosphatases

September 2023

Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.

Ack1 is a nonreceptor tyrosine kinase that is associated with cellular proliferation and survival. The receptor tyrosine kinase Mer, a member of the TAM family of receptors, has previously been reported to be an upstream activator of Ack1 kinase. The mechanism linking the two kinases, however, has not been investigated.

View Article and Find Full Text PDF
Article Synopsis
  • Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options and this study explores resistance mechanisms to BH3 mimetics and the effectiveness of a new drug, NWP-0476, both alone and in combination.
  • The research used BH3 profiling and phosphokinase arrays to reveal that T-ALL cells rely on different proteins (BCL-xL and BCL-2) for survival, leading to the discovery of enhanced LCK and ACK1 activity in resistant cells as potential resistance factors.
  • The study concluded that targeting the LCK and ACK1 signaling pathways, along with combining BH3 mimetics and tyrosine kinase inhibitors, could offer a promising treatment strategy for relapsed T-
View Article and Find Full Text PDF

Hormone receptor-positive, HER2-negative advanced breast cancers exhibit high sensitivity to CDK4/6 inhibitors such as palbociclib. However, most patients inevitably develop resistance, thus identification of new actionable therapeutic targets to overcome the recurrent disease is an urgent need. Immunohistochemical studies of tissue microarray revealed increased activation of non-receptor tyrosine kinase, ACK1 (also known as TNK2) in most of the breast cancer subtypes, independent of their hormone receptor status.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!